Application of ovR2E in curative effect of HBV infection treatment

A 1. ovr2e, protein technology, applied in the field of molecular biology, can solve only 30-50% of the problems

Inactive Publication Date: 2016-03-16
SHENZHEN NANSHAN DISTRICT PEOPLES HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, IFN-α is one of the first-line drugs for the treatment of patients with chronic hepatitis B (chronichepatitisB, CHB). The response rate of IFN-α treatment for CHB is still only 30-50%, and the long-term reactivation rate is still high. Therefore, how to increase the activity of IFN-α to inhibit HBV replication and improve its antiviral treatment effect is urgent one of the clinical problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ovR2E in curative effect of HBV infection treatment
  • Application of ovR2E in curative effect of HBV infection treatment
  • Application of ovR2E in curative effect of HBV infection treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The preferred embodiments of the present invention will be further described in detail below in conjunction with the accompanying drawings.

[0031] In vitro expression and purification of ovR2E protein and completion of its ligand binding experiment:

[0032] (1) Construction of prokaryotic expression vectors and protein purification of sheep ovR2E and shIFNAR-2a:

[0033] Trizol was used to extract total RNA from sheep lung fibroblast-like cells (cell number: SheepL1), and RT-PCR amplified the mRNA of extracellular domain of ovine type I interferon receptor subunit 2 (ovR2E for short), and the amplification primers were: :

[0034] ovR2ER: 5-AGACGCGGATCCTCGTATGTTGTGCCTGATCT-3

[0035] ovR2EL:5-CCGCTAGAATTCTTATGTAGCAGGTTCTGATGACT-3,

[0036] The amplified ovR2E gene fragment is the main extracellular active region of sheep IFNAR2 (amino acids 27-246) (ProcNatlAcadSciUSA.2001;98(11):6138-43), and the amino acid sequence is as follows:

[0037] MLLSQNVSAIGPLNLYPMVHIS...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides application of ovR2E in a curative effect of HBV infection treatment. The application of the ovR2E in the curative effect of HBV infection treatment is characterized in that the ovR2E protein is combined with hIFN-alpha to promote combination of a ligand and hIFNA-2c, and the ligand inhibition HBV replication activity is strengthened. According to the technical scheme, the ovR2E protein improves the hIFN-alpha inhibition HBV replication level, hR2a protein does not have strengthening and regulating effects on ligand inhibition HBV replication action, the ovR2E protein can be combined with the hIFN-alpha and strengthen the ligand inhibition HBV replication activity, a foundation is laid for the situation that the ovR2E protein and the hIFN-alpha are prepared into a mixture used for improving the curative effect of the hIFN-alpha on treating CHB in future, and a new approach is provided for treating the CHB.

Description

technical field [0001] The invention relates to the technical field of molecular biology, in particular to the application of the curative effect of ovR2E protein in the treatment of HBV infection. Background technique [0002] Hepatitis B virus (hepatitis B virus) is a DNA virus that causes acute and chronic hepatitis in humans. Today, HBV infection is a serious threat to human health. About one million people die every year from liver failure, cirrhosis and liver cancer caused by HBV infection. . [0003] At present, IFN-α is one of the first-line drugs for the treatment of patients with chronic hepatitis B (chronichepatitisB, CHB). The response rate of IFN-α treatment for CHB is still only 30-50%, and the long-term reactivation rate is still high. Therefore, how to increase the activity of IFN-α to inhibit HBV replication and improve its antiviral treatment effect is urgent One of the clinical problems. [0004] Human IFN-α (humanIFN-α, hIFN-α) combines with human type...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61P31/20
Inventor 余治健邓启文陈重程航邓向斌李多云郑金鑫
Owner SHENZHEN NANSHAN DISTRICT PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap